Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Important Orders for Safeture's Platform

Exlog Global, a leading security and risk management partner of Safeture, has signed four new multi-year agreements with global organizations leveraging Safeture's platform. The agreement will help the organizations to protect what matters most – their people.The deals signed by Exlog Global are another important milestone for Safeture  into the American market. The new clients include: · A global provider of highly engineered, mission-critical processing equipment and systems. · A well-known SaaS organization focusing on website building and hosting. · A

Rejlers has been selected as a partner for the preparation of Spinnova’s process design package

SPINNOVA PLC, PRESS RELEASE, 12 February 2024, 10:00 a.m. EET  Rejlers has been selected as a partner for the preparation of Spinnova’s process design package   Spinnova, the sustainable textile material company and Rejlers Finland Oy, the technical design and consulting company have agreed on cooperation in the preparation of a process design package for Spinnova's fibre production technology. The preparation of the process design package is an essential part of the planning for the scaling of SPINNOVA® fibre production. The process design package cooperation includes expert

Navamedic ASA launches Eroxon®

Oslo, 12 February 2024 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, has acquired rights to market and distribute Eroxon® in the Nordic countries. Eroxon® is clinically proven and considered a breakthrough in treatment of erectile dysfunction for men.Already a success in pharmacies in the UK, the product was launched in Norway this week. It can be bought online and at pharmacies across the country without a doctor’s prescription. Roll-out in Sweden is being planned in May this year. Denmark and Finland will

Notice convening the Annual General Meeting 2024

Notice is given to the shareholders of Svenska Cellulosa Aktiebolaget SCA (“SCA”), Reg. No. 556012-6293,of the Annual General Meeting of shareholders to be held on Friday, March 22, 2024, at 1.00 p.m. in Sundsvall at Clarion Hotel Sundsvall (registration from 11.30 a.m.)   The shareholders also have the opportunity to exercise their voting rights by postal voting prior to the Meeting. Right to participate and notice of participation at the meeting venue Shareholders who wish to participate in the Annual General Meeting at the meeting venue in person or by proxy must · be

BioStock: BiBB's founder on the first US clinical cases with EndoDrill

BiBBInstruments is a medical device company, based in Lund, developing EndoDrill – an electric-driven endoscopic ultrasound device for tissue sampling. The company recently announced the first successful clinical cases with EndoDrill GI in the US. BiBB’s founder, Dr Charles Walther, stopped by the BioStock Studio to give us the details.Watch the interview with Dr Charles Walther at biostock.se: BiBB’s founder on the first US clinical cases with EndoDrill - BioStock This is a press release

2020 Bulkers Ltd. (2020) – Sale of Bulk Shanghai and Bulk Seoul

Oslo, Norway, February 12, 2024 2020 Bulkers Ltd. (the “Company”) announces that it has signed an agreement to sell its 2019 built Newcastlemax vessels Bulk Shanghai and Bulk Seoul to an unaffiliated third party for a total consideration of US$127.5 million. The sale is subject to certain closing conditions, in line with industry standards. The two vessels are currently owned by Ocean Yield under a sale leaseback arrangement, and the Company has exercised its option with Ocean Yield to effectuate the sale. The Company will retain the vessels’ operating cashflow until closing of the

A science-based guideline for companies to extend their climate work and indicate the environmental benefits of their circular economy solutions

Press release 12 February, 2024  The updated handprint guideline created by VTT and LUT University offers companies a transparent and rigorous way to demonstrate the positive environmental impacts of circular solutions. In addition, the handprint approach can be considered as a means to target global climate neutrality. By following the handprint guideline, companies have a science-based way to assess and communicate their positive impacts on the environment.“The results of the project can make a significant impact on the way companies plan and communicate their environmental and

New order received for the Innovative TSE Cancer Treatment Technology

Scandinavian ChemoTech’s Animal Care division has received an order for USD 30,000 from one of its largest clients in the United States. The order is for an additional vetIQure™ TSE (Tumour Specific Electroporation™) system, an innovative and minimally invasive treatment for various types of cancers in animals.   In less than a year, the Animal Care division has received orders for five vetIQure TSE systems and several treatment kits from one single account. The vetIQure TSE system is a patented solution designed to improve clinical outcomes for veterinarians treating cancer and is

Crunchfish Digital Cash and SaaS Expand target mobile operators in Africa

Crunchfish’s sales efforts have mainly been aimed towards India and the CBDC community. In Africa, mobile payments have become an integral part of the economy, but the lack of sufficient infrastructure and internet connectivity is a limiting factor. With offline payment support, the power of mobile payments in Africa can reach its full potential. A partnership has been entered with SaaS Expand to develop opportunities that this brings for Crunchfish Digital Cash.[En bild som visar Teckensnitt, Grafik, logotyp, symbol Automatiskt genererad beskrivning]   Mobile payments have become an

Brain+ nominates an international digital health industry expert and experienced investor profile as new chairman candidate

COMPANY ANNOUNCEMENT  Brain+ A/S (Nasdaq First North: BRAINP) - This information is information that Brain+ A/S is obliged to publish in accordance with the EU Market Abuse Regulation. The information was provided by the contact person below for publication on February 12, 2024  ·Tim Juergens, who is a strong believer in the potential of digital therapeutics, will be up for election at Brain+’ Annual General Meeting on May 15, 2024, and until then act as active board observer and strategic partner to management  ·In the interim, Johan Luthman, who has been on the company’s

Buybacks of shares in ITAB during week 6 2024

During the period between 5 and 9 February 2024, ITAB Shop Concept AB (publ) (”ITAB”) (LEI-code: 2138001H6FCSZBP26351) has repurchased in total 152,517 own ordinary shares (ISIN: SE0015962097) as part of the share buyback program initiated by the Board of Directors in order to optimise the capital structure.The share buybacks form part of the share buyback program in a maximum amount of MSEK 50 that ITAB announced on 28 September 2023. The share buyback program, which runs from 29 September 2023 until 14 May 2024, is being carried out in accordance with the EU Market Abuse Regulation (“MAR”)

Valmet to start the share buy-back program for its share-based incentive plans

Valmet to start the share buy-back program for its share-based incentive plans Valmet Oyj’s press release on February 12, 2024 at 9:30 a.m. EET   Valmet announced on December 20, 2023, that the Board of Directors of Valmet has decided to use the authorization granted by the Annual General Meeting held on March 22, 2023, to repurchase the Company’s own shares. Based on the authorization, the Board has decided to initiate a fixed-term share buy-back program for the purpose of acquiring the Company's own shares to meet part of the obligations arising from its share-based long-term

Year-end report 2023

NET ASSET VALUE AND THE LATOUR SHARE · The net asset value increased to SEK 198 per share, compared with SEK 159 per share at the start of the year. This is an increase of 27.5 per cent, adjusted for dividends. By comparison, the Stockholm Stock Exchange’s Total Return Index (SIXRX) increased by 19.2 per cent. The net asset value was SEK 190 per share on 9 February.[1] · The total return on the Latour share was 35.4 per cent during the period, compared to SIXRX which increased by 19.2 per cent. · The Board of Directors proposes an increased dividend of SEK 4.10 (3.70) per share.

TF Bank: Monthly statistics January 2024

The total loan portfolio amounted to SEK 18,268 million at the end of January. Compared to January 2023, the loan portfolio has increased by 25 % in local currencies.  Month Jan-24 Jan-23 ChangeConsumer Lending   New lending, SEK million 456 488 -7 %Credit Cards   New lending, SEK million 1,097 592 85 %Ecommerce Solutions   Transaction volume*, SEK million 977 968 1 % *The sum of all purchases that go through TF Bank’s payment solutions All figures for January 2024 are preliminary. For

The construction of the Enviro’s plant in Uddevalla has received starting notice

The construction of Scandinavian Enviro Systems’ end-of-life tire recycling plant in Uddevalla has receieved starting notice. As previously communicated, the company expects the construction of the plant to start during the first quarter 2024.It is the municipality of Uddevalla that has notified about the permit in a letter. On February 7, Enviro, Antin Infrastructure Partners and Michelin announced the final investment decision for the plant and that the joint venture, formed between Enviro and Antin, has started to place orders for key materials and machinery for the plant. General

Repurchase of Outokumpu’s own shares

Outokumpu OyjStock exchange releaseFebruary 12, 2024 at 9.30 am EETRepurchase of Outokumpu’s own shares On February 9, 2024, Outokumpu has completed repurchases of its own shares as follows (ISIN FI0009002422): +-------+----------------+------------------------------------+----------------+|Trading|Number of shares|Weighted average price / share, EUR*|Total cost, EUR*||venue | | | |+-------+----------------+------------------------------------+----------------+|XHEL |877 |4.114

Nobia to focus on the Nordic and the UK markets – divests Bribus in the Netherlands

Nobia has taken a strategic decision to focus on its core Nordic and UK markets and continues with activities to strengthen the financial position. The Group’s strategic initiatives focus on maximising cost efficiency, realising the full potential of the Nordic region (e.g., through the new automated factory in Jönköping and harmonised product ranges) and executing the UK transformation program.In line with this decision, Nobia has entered into an agreement to divest its subsidiary Bribus to the Dutch long-term investor O2 Capital Partners. Bribus is part of Nobia’s Portfolio Business Units

Altor completes the public cash offer to the shareholders of Permascand and acquires over 90% of the shares

On December 19, 2023, Altor PC AB (Altor), a company controlled by Altor Fund VI (No. 1) AB and Altor Fund VI (No. 2) AB[1], announced a public cash offer to the shareholders of Permascand. On February 5, 2024, Altor announced the completion of the public cash offer, whereby it acquires approximately 95% of the shares in Permascand. Settlement of shares tendered on or before February 2, 2024, is expected to commence around February 12, 2024. Altor will promote a delisting of Permascand’s shares from Nasdaq First North Growth Market.Ever since Permascand was founded in 1971 they have built

Metso to deliver cooling solution for Aurubis Bulgaria Flash Smelting Furnace rebuild

Metso Corporation’s press release on February 12, 2024, at 09:00 a.m. EETAurubis Bulgaria AD has awarded Metso a contract for a copper Flash Smelting Furnace rebuild project located in the Zlatitsa-Pirdop Valley in Bulgaria. The value of the contract exceeds EUR 10 million, and it is booked in the Minerals segment’s first-quarter 2024 order intake.  The Outotec® Flash Smelting Furnace and related technologies were implemented at the Bulgarian primary copper smelter already in 1987; since then, various upgrades and improvements have been done at regular intervals in close cooperation

Cloudberry Clean Energy ASA | Invitation to presentation of fourth quarter 2023 results

Oslo, Norway, 12 February 2024: Cloudberry Clean Energy ASA (“Cloudberry” or the “Company”) will publish its fourth quarter results on 15 February 2024 at 07:00 CET. The company management will host a presentation and Q&A session at 11:00 CET.Please use the following link to access the live presentation and Q&A session: https://tv.streamfabriken.com/cloudberry_clean_energy_asa_q4_2023/register The fourth quarter 2023 report and presentation material, and the link/recording to the webcast will be made available at www.cloudberry.no.For further information, visit our company and IR

Transaction in Own Shares

    12 February 2024 Vesuvius plc Share Buyback Programme – Transactions in Own Securities   Vesuvius plc (the "Company") announces that it has purchased the following number of its Ordinary Shares of 10p each from Jefferies International Limited (the “Broker”), pursuant to the terms of its Share Buyback Programme announced on 4 December 2023:   +---------------------------------------------------------------+----------+|Date of purchase: |09/02/2024|+----------------------------------------------------------

WntResearch continues to the next step in the phase 2 study NeoFox with the highest evaluated dose of Foxy-5

WntResearch announces today that the company, after a very fast patient recruitment, has been able to determine that the highest evaluated dose (8 mg/kg) of the drug candidate Foxy-5 will be used in the next step of the proof of concept study NeoFox. Approximately 80 patients with colon cancer will be treated in the second part of the study and an initial efficacy analysis is planned as early as the end of 2024.Previously reported ad hoc observations in patients with colon cancer indicate that the company's drug candidate Foxy-5 has a tumor-inhibiting effect already after three weeks of

Orexo and Sobi agree to advance feasibility study with AmorphOX

· Orexo and Sobi advance collaboration after successful exploratory feasibility study with the company´s world-class drug delivery platform, AmorphOX® · The feasibility study confirmed that the biomolecule retained its activity after formulation with AmorphOX · Orexo has patent applications for AmorphOX formulations relating to biomolecules.   Uppsala, Sweden – February 12, 2024 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), today announces the company agreed with Swedish Orphan Biovitrum AB (publ.) (Sobi) to advance the successful exploratory feasibility study initiated last year.

Dr. Bami Bastani is nominated as the Chairman of the Board of Directors of Sivers Semiconductors AB and is appointed Executive Chairman of Sivers Semiconductors Inc.

Kista, Sweden // Feb.12, 2024 // Sivers Semiconductors AB (STO: SIVE) today announced that its subsidiary, Sivers Semiconductors Inc., has appointed Dr. Bami Bastani as US Executive Chairman and has been nominated as the Chairman of the Board of Directors of Sivers Semiconductors AB.Dr. Bastani joined Sivers' team as Strategic Advisor to the Board and the Management team in August 2023. He brings over 42 years of semiconductor industry experience, most recently as Senior Vice president at GlobalFoundries and GlobalFoundries' board member at the Global Semiconductor Alliance (GSA). Prior to

There are no items matching the current filter
There are no more items matching the current filter
Back to top